A Maryland pathologist and MedChi past president explains how all-or-nothing contracts, anti-steering clauses and private equity deals inflate costs. He also outlines the federal and state reforms that could restore competition.
Paying membership fees with pretax employer dollars held cost growth to 0.9% a year, but the numbers come with caveats physicians should know before pitching employers.
As physicians, payers and independent reviewers all adopt AI for utilization review and No Surprises Act disputes, audit trails and human oversight will determine which practices come out ahead.
An AI scribe's price tag is only part of its cost. A three-part framework helps physicians and practice managers measure return on investment, clinician well-being and the time it really takes to get the tool working.